Breast Lesion Localization Methods Market To Reach $2.2 Billion By 2033

Breast Lesion Localization Methods Market Growth & Trends

The global breast lesion localization methods market size is anticipated to reach USD 2.2 billion by 2033 and is anticipated to grow at a CAGR of 7.3% from 2026 to 2033, according to a new report by Grand View Research, Inc. Increasing government and non-government reimbursement policies for breast cancer diagnostics, biopsies, examinations, and related medical procedures are projected to drive adoption of breast lesion localization methods. Furthermore, the growing demand for improved healthcare infrastructure and facilities, driven by the rising prevalence of the disease among women, is anticipated to boost the market growth.

As the incidence of breast cancer among women rises, there is a heightened need for precise and early detection methods. Breast lesion localization techniques are pivotal in accurately identifying and targeting suspicious lesions for biopsy or surgical intervention. For instance, As per a report by National Breast Cancer Foundation, Inc., in April 2024, approximately 1 out of every 8 women in the U.S. will receive a breast cancer diagnosis during her lifetime. In 2024, it is projected that around 310,720 women and 2,800 men will be diagnosed with invasive breast cancer. With the increasing prevalence of breast cancer, there is a growing focus on tailored treatment strategies. Advanced lesion localization methods empower oncologists and surgeons to meticulously plan and deliver treatments, aiming for the best possible patient outcomes. These factors are driving the demand for breast lesions localizations methods.

Advancements in imaging technologies like digital mammography, ultrasound, and MRI have greatly improved the detection and characterization of breast lesions. As a result, there is an increased need for precise localization techniques to guide surgical procedures accurately. Furthermore, the integration of 3D imaging modalities and navigation systems allows surgeons to visualize breast lesion locations in real-time during procedures, significantly enhancing surgical precision and improving patient outcomes. These factors are propelling the market growth over the forecast period.

 Request a free sample copy or view report summary: Breast Lesion Localization Methods Market Report

Breast Lesion Localization Methods Market Report Highlights

• Based on type, the wire-guided localization segment held the largest market share in 2025 owing to the presence of a wide range of products and high adoption of this technique among end-users.

• The ultrasound-guided localization segment dominated the breast lesion localization methods industry, accounting for 43.8% revenue share in 2025. This dominance is supported by the widespread availability of ultrasound systems, real-time visualization of breast lesions, and the absence of ionizing radiation.

• The malignant breast lesions segment dominated the breast lesion localization methods market, accounting for 64.4% in 2025. This dominance is driven by the rising global incidence of breast cancer, increasing detection of early-stage and non-palpable malignant lesions through organized screening programs, and the widespread adoption of breast-conserving surgery, which requires precise preoperative lesion localization.

• The same-day localization procedures segment dominated the breast lesion localization methods market, accounting for 50.5% revenue share in 2025. This dominance is driven by the widespread use of conventional wire-guided localization, which is performed on the day of surgery.

• The hospitals segment dominated the breast lesion localization methods industry, accounting for 59.7% revenue share in 2025. This dominance is driven by the availability of advanced diagnostic imaging systems, specialized breast surgery departments, multidisciplinary breast care teams, and comprehensive oncology infrastructure within hospitals.

• North America dominated the market with the highest revenue share in 2025 owing to the presence of key manufacturers in the region, established healthcare infrastructure, and high adoption of localization devices.

Breast Lesion Localization Methods Market Segmentation

Grand View Research has segmented the global breast lesion localization methods market report based on type, imaging guidance modality, lesion type, procedure setting, end use, and region:

Breast Lesion Localization Methods Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)

• Wire-Guided Localization (WGL)

• Radioisotope-Based Localization

  • Radio-Guided Occult Lesion Localization (ROLL)

  • Radioactive Seed Localization (RSL)

• Magnetic Localization

  • Magnetic Seed Localization

  • Magnetic Tracer Localization

• Radar-Based Localization

• Radiofrequency Identification (RFID)-Based Localization

• Electromagnetic Localization

• Others

Breast Lesion Localization Methods Imaging Guidance Modality Outlook (Revenue, USD Million/Billion, 2021 - 2033)

• Mammography-Guided Localization

• Ultrasound-Guided Localization

• MRI-Guided Localization

• Tomosynthesis-Guided Localization

• Others

Breast Lesion Localization Methods Lesion Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)

• Malignant Breast Lesions

• Benign Breast Lesions

• High-Risk Breast Lesions

Breast Lesion Localization Methods Procedure Setting Outlook (Revenue, USD Million/Billion, 2021 - 2033)

• Same-Day Localization Procedures

• Preoperative Localization Procedures (1-30 days before surgery)

Breast Lesion Localization Methods End Use Outlook (Revenue, USD Million/Billion, 2021 - 2033)

• Hospitals

• Ambulatory Surgery Centers (ASCs)

• Specialty Breast Centers

• Diagnostic Imaging Centers

Breast Lesion Localization Methods Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Thailand

  • Australia

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Breast Lesion Localization Methods Market

• Merit Medical Systems

• Hologic, Inc.

• MOLLI Surgical (Stryker) 

• Sirius Medical Systems B.V.

• Elucent Medical

• Becton, Dickinson and Company

• Cook Group Incorporated (Cook Medical)

• Argon Medical Devices

• IsoAid, LLC

• Mammotome (Danaher Corporation)

• Geotek Medical